Development of Orphan Vaccines: An Industry Perspective (Q27487916)

Emerging Infectious Diseases

published in

6 references

20 June 2019

19 September 2019

2 October 2020

17 December 2020

22 August 2022

7 February 2024

5

0 references

issue

6

0 references

page(s)

749-56

0 references

cites work

The introduction of new vaccines into developing countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

A cross-national comparison of orphan drug policies: implications for the U.S. Orphan Drug Act.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Orphan drugs: the question of products liability.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

What have been the strategies for the registration, positioning and control of medical information for intramuscular artemether?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Will ethical and liability issues and public acceptance allow maternal immunization?

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Rare diseases and "orphan" drugs.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Prospects for the use of new vaccines in developing countries: cost is not the only impediment.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Bumps on the vaccine road.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Orphan drugs. Improved medical treatment of rare diseases

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Orphan products: origins, progress, and prospects

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Report on a meeting of a working party sponsored by the European Commission to discuss the ethical, legal and social aspects of research on vaccines and vaccination (BIOMED2 BMH4 983 197).

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

Will the fight against tropical diseases benefit from orphan drug status?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640802

A systematic method for evaluating the potential viability of local vaccine producers

27 November 2018

1 reference

12 December 2020

[Orphan drugs: problem of public health and economic stakes]

1 reference

12 December 2020

Economic evaluations applied to HB vaccination: general observations

1 reference

12 December 2020

Drugs trying to get the parents: there will be incentives for the European scientific community to develop research in the field of the orphan drugs

1 reference

12 December 2020

Sustainable introduction of affordable new vaccines: the targeting strategy

1 reference

12 December 2020

A framework for the evaluation of vaccines for use in the expanded programme on immunization

1 reference

12 December 2020

The United States needs a national vaccine authority

1 reference

12 December 2020

Evaluation of orphan products by the U.S. Food and Drug Administration

1 reference

12 December 2020

The development of orphan drugs--a pharmaceutical company perspective

1 reference

12 December 2020

Public-private partnerships--business as usual?

1 reference

12 December 2020